AGED;
ARTICLE;
B CELL LYMPHOMA;
CASE REPORT;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
KARYOTYPE;
LYMPH NODE BIOPSY;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
Genetic and molecular pathogenesis of mantle cell lymphoma: Perspectives for new targeted therapeutics
Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat. Rev. Cancer 2007 7 750 762.
Jaffe ES, Harris NL, Stein H et al. eds. World Health Organisation classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon : IARC Press, 2001 119 187.
Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody
Cheuk W, Wong KOY, Wong CSC, Chan JKC. Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody. Am. J. Surg. Pathol. 2004 28 801 807.
Antibody selection in immunohistochemical detection of cyclin D1 in mantle cell lymphoma
Torlakovic E, Nielsen S, Vyberg M. Antibody selection in immunohistochemical detection of cyclin D1 in mantle cell lymphoma. Am. J. Clin. Pathol. 2005 124 782 789.
The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement
Chang B, Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol. Today 1994 15 367 373.
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome
Kienle D, Krober A, Katzenberger T et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003 102 3003 3009.
Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry
Zukerberg LR, Yang WI, Arnold A et al. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am. J. Clin. Pathol. 1995 103 756 760.
Expression of cyclin D3 and cyclin e and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas
Bai M, Tsanou E, Agnantis NJ et al. Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas. Histol. Histopathol. 2003 18 449 457.
Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas
Chang CC, Liu YC, Cleveland RP et al. Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas. Am. J. Clin. Pathol. 2000 113 512 518.
A small subset of CD5-negative diffuse large B-cell lymphomas express nuclear cyclin D1 with evidence of amplified cyclin D1 signals or the t(11;14) translocation
[Abstract].
Ehinger M, Linderoth J, Christensson B et al. A small subset of CD5-negative diffuse large B-cell lymphomas express nuclear cyclin D1 with evidence of amplified cyclin D1 signals or the t(11;14) translocation. Blood 2006 108 579 [Abstract].
Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
Bodrug SE, Warner BJ, Bath ML et al. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 1994 13 2124 2130.
